- Clinical Trials
- Research News
- Industry Trends
- Agency Actions
- Drug Safety Issues
- Approvals, Launches, & New Indications
- Health Care Reform
Endocrinology Groups Issue Top Five Recommendations
Experts identify questionable practices (October 21)
As part of the ongoing Choosing Wisely campaign, the Endocrine Society and the American Association of Clinical Endocrinologists (AACE) have released a list of “Five Things Physicians and Patients Should Question.”
Members of the Society along with representatives of the AACE formed a joint task force to identify tests or procedures that should be used only in specific circumstances. The task force identified several items for possible inclusion. Subsequent discussions compared the evidence supporting each item, the value of the recommendation to practitioners, and the potential for cost savings. Using these criteria, the task force voted for their top five recommendations from the original list.
These recommendations are:
- Avoid routine multiple daily self-glucose monitoring in adults with stable type 2 diabetes receiving agents that do not cause hypoglycemia.
- Don’t routinely measure 1,25-dihydroxyvitamin D unless the patient has hypercalcemia or decreased kidney function.
- Don’t routinely order a thyroid ultrasound in patients with abnormal thyroid function tests if there is no palpable abnormality of the thyroid gland.
- Don’t order a total or free T3 level when assessing the levothyroxine (T4) dose in hypothyroid patients.
- Don’t prescribe testosterone therapy unless there is biochemical evidence of testosterone deficiency.
Source: Choosing Wisely; October 21, 2013.